Stay updated on Daratumumab in PGNMID and C3 GN Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in PGNMID and C3 GN Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3. This appears to be a minor page update.
    Difference
    0.1%
    Check dated 2026-03-07T13:07:52.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    - Updated page revision tag from v3.4.1 to v3.4.2; no impact on study content or user workflow.
    Difference
    0.1%
    Check dated 2026-02-14T01:44:33.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    An administrative version update is shown: 'Revision: v3.4.1' was added and 'Revision: v3.4.0' was removed. This appears to be metadata about the site and does not alter study data or page content.
    Difference
    0.1%
    Check dated 2026-02-06T14:23:24.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added UI elements and labels: Show glossary and Hide glossary, and updated metadata fields with 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', plus Revision: v3.4.0. Removed or replaced older labels: 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4.
    Difference
    0.4%
    Check dated 2026-01-23T10:17:51.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4, replacing Revision: v3.3.3. No substantive content or layout changes are evident.
    Difference
    0.1%
    Check dated 2026-01-16T06:40:06.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Added Minnesota as a location under the Locations section and removed the HHS Vulnerability Disclosure text/link from the footer.
    Difference
    0.2%
    Check dated 2025-12-18T12:24:07.000Z thumbnail image

Stay in the know with updates to Daratumumab in PGNMID and C3 GN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.